Researchers developed a copper-64-labeled monoclonal antibody immunoPET tracer that successfully tracked human CD19-positive B cells in the central nervous system of a multiple sclerosis mouse model. The work demonstrates targeted imaging of a defined immune population within the brain, moving beyond indirect inflammation readouts. The preclinical results support immunoPET as a potential approach for quantifying immune cell localization and dynamics in neuroinflammatory disease settings. For imaging developers, the study adds a technical proof point for tracer specificity, brain signal detection, and feasibility for future translation to human biomarker strategies.
Get the Daily Brief